Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.
about
Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands.A benefit-risk assessment of the use of proton pump inhibitors in the elderly.ACG and CAG Clinical Guideline: Management of Dyspepsia.Proton pump inhibitors and risk of bone fractures.
P2860
Canadian Association of Gastroenterology position statement: hip fracture and proton pump inhibitor therapy-a 2013 update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@en
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@nl
type
label
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@en
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@nl
prefLabel
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@en
Canadian Association of Gastro ...... hibitor therapy-a 2013 update.
@nl
P2860
P356
P1476
Canadian Association of Gastro ...... nhibitor therapy-a 2013 update
@en
P2093
CAG Clinical Affairs
Grigorios Leontiadis
P2860
P304
P356
10.1155/2013/321379
P407
P577
2013-10-01T00:00:00Z